Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) Bundle
Wuxi Paike New Materials (605123.SS) presents a mixed but compelling picture for investors: Q3 2025 revenue reached 903.38 million CNY (up 7.97% QoQ) driving a TTM revenue of 3.41 billion CNY (Y/Y +3.24%) despite a -11.21% annual drop to 3.21 billion CNY in 2024; profitability metrics show a TTM ROE 5.65% and net margin of 7.46% with Q3 EPS at 0.51 CNY (vs 0.68 CNY a year earlier) and a P/E of 33.24, while balance-sheet figures reveal conservative leverage (debt/equity 0.16), strong interest coverage (12.88), but signs of cash strain (Debt/FCF -13.76 and no positive P/FCF), alongside robust operating cash flow of 10.87 billion CNY (TTM, +35% YoY), a revenue-per-employee of 2.99 million CNY across 1,140 staff, and a market capitalization of 10.56 billion CNY (as of Dec 12, 2025) with a P/S of 2.48 and P/B of 1.83-read on to unpack what these numbers mean for upside, valuation risks, and strategic growth opportunities.
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) - Revenue Analysis
Wuxi Paike's recent revenue trajectory shows quarter-over-quarter recovery with mixed annual results. Key headline figures provide a snapshot of scale, efficiency and market valuation relative to sales.
- Q3 2025 revenue: 903.38 million CNY (+7.97% vs prior quarter)
- Trailing twelve months (TTM) revenue: 3.41 billion CNY (+3.24% YoY)
- Full-year 2024 revenue: 3.21 billion CNY (‑11.21% YoY decline)
- Revenue per employee: ~2.99 million CNY (1,140 employees)
- Price-to-Sales (P/S) ratio: 2.48
- Market capitalization (as of 2025-12-12): 10.56 billion CNY (+52.92% YoY)
| Metric | Value | Period / Note |
|---|---|---|
| Quarterly Revenue | 903.38 million CNY | Q3 2025 (+7.97% QoQ) |
| TTM Revenue | 3.41 billion CNY | Trailing 12 months (+3.24% YoY) |
| Annual Revenue (2024) | 3.21 billion CNY | 2024 (‑11.21% YoY) |
| Revenue per Employee | ~2.99 million CNY | 1,140 employees |
| Price-to-Sales (P/S) | 2.48 | Market valuation vs sales |
| Market Capitalization | 10.56 billion CNY | As of 2025-12-12 (+52.92% YoY) |
Implications for revenue quality and investor valuation considerations:
- QoQ growth in Q3 2025 signals near-term demand recovery after 2024's annual contraction.
- TTM growth of 3.24% indicates modest year-over-year improvement despite the prior-year decline.
- Revenue per employee (~2.99M CNY) suggests relatively high productivity for the staff base, supporting margin potential if costs remain controlled.
- A P/S of 2.48 reflects a market willing to pay a mid-range premium on sales - investors should compare this to peers in advanced materials to assess relative valuation.
- Market cap up 52.92% year-over-year indicates strong market sentiment or multiple expansion despite mixed revenue trends.
Further contextual detail and shareholder positioning can be found here: Exploring Wuxi Paike New Materials Technology Co.,Ltd. Investor Profile: Who's Buying and Why?
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) - Profitability Metrics
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) shows moderate profitability with key ratios pointing to modest returns relative to asset and equity bases. Below are the headline metrics investors watch when assessing earnings quality and capital efficiency.- Trailing Twelve Months (TTM) Return on Equity (ROE): 5.65% - indicates moderate profitability for shareholders.
- Net Profit Margin: 7.46% - proportion of revenue that becomes net income.
- Earnings Per Share (EPS), Q3 2025: 0.51 CNY (down from 0.68 CNY in Q3 2024) - year-over-year decline signaling near-term earnings pressure.
- Price-to-Earnings (P/E) Ratio: 33.24 - valuation implying investor expectations for future growth despite current margins.
- Return on Assets (ROA): 1.65% - modest asset efficiency in generating profit.
- Return on Invested Capital (ROIC): 2.43% - limited returns on capital deployed.
| Metric | Value | Period / Note |
|---|---|---|
| ROE (TTM) | 5.65% | Trailing Twelve Months |
| Net Profit Margin | 7.46% | Latest reported |
| EPS | 0.51 CNY | Q3 2025 (vs 0.68 CNY in Q3 2024) |
| P/E Ratio | 33.24 | Based on current share price and trailing earnings |
| ROA | 1.65% | Latest reported |
| ROIC | 2.43% | Latest reported |
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) - Debt vs. Equity Structure
Wuxi Paike New Materials Technology Co.,Ltd. displays a conservative capital structure by headline metrics, with low leverage but pockets of cash-flow strain. Key quantitative indicators highlight the balance between prudent borrowing and operational cash dynamics.- Debt-to-Equity: 0.16 - indicates limited use of debt relative to shareholder equity, reducing financial risk from leverage.
- Interest Coverage: 12.88 - EBIT covers interest expenses by almost 13x, signaling comfortable interest-servicing capacity under current earnings.
- Debt-to-EBITDA: 2.10 - moderate leverage when compared to EBITDA; often viewed as manageable but warrants monitoring versus peers and industry cycles.
- Debt-to-Free Cash Flow: -13.76 - negative free cash flow produces a large (negative) ratio, reflecting that available cash generation is currently insufficient for routine capital/debt needs.
| Metric | Value | Comment |
|---|---|---|
| Total Assets | >5,000,000,000 CNY | Scale of balance sheet supporting operations and collateral capacity |
| Registered Capital | 121,000,000 CNY | Legal capital base |
| Shares Outstanding | 121.17 million | Float and market capitalization base |
| Insider Ownership | 59.05% | High insider alignment; potential concentration risk |
| Institutional Ownership | 12.23% | Relatively low institutional holding |
| Debt-to-Equity | 0.16 | Conservative leverage |
| Interest Coverage | 12.88 | Strong earnings-to-interest buffer |
| Debt/EBITDA | 2.10 | Moderate leverage relative to cash operating profits |
| Debt/Free Cash Flow | -13.76 | Reflects negative free cash flow impacts on debt service |
- Low Debt-to-Equity (0.16) provides headroom for future borrowing if strategic investment or acquisitions arise.
- High interest coverage (12.88) reduces near-term refinancing pressure and supports creditworthiness.
- Debt-to-EBITDA at 2.10 is within commonly accepted moderate ranges but should be tracked against EBITDA volatility.
- Negative free cash flow driving a -13.76 Debt/FCF signals that despite low nominal leverage, cash-generation issues could constrain debt repayment flexibility or necessitate equity or financing actions.
- Insider ownership (59.05%) aligns management and large shareholders, but may limit liquidity and the influence of public minority shareholders; institutions hold 12.23%, suggesting limited external analyst/institutional scrutiny.
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) - Liquidity and Solvency
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) presents a solid short-term liquidity profile and improving cash-generation metrics that support operational resilience and creditor confidence.- Current ratio: 1.96 - the company holds nearly 2.0 CNY in current assets for every 1.0 CNY of current liabilities, indicating adequate capacity to meet short-term obligations.
- Quick ratio: 1.51 - excluding inventory, the company still maintains strong immediate liquidity, with 1.51 CNY of liquid assets per 1.0 CNY of current liabilities.
- Operating cash flow (TTM): 10.87 billion CNY - up 35.0% year-over-year, signaling materially stronger cash generation from core operations.
- Enterprise value: 9.13 billion CNY - reflects combined market value and net debt exposure, useful for valuation comparisons.
- Market capitalization: 8.46 billion CNY - provides the market's equity valuation of the firm.
- Employees: 1,140 - headcount supporting production, R&D and commercial activities, relevant to operating leverage and cost structure.
| Metric | Value | Implication |
|---|---|---|
| Current Ratio | 1.96 | Comfortable short-term coverage |
| Quick Ratio | 1.51 | Liquidity without relying on inventory |
| Operating Cash Flow (TTM) | 10.87 bn CNY | Strong cash conversion; +35.0% YoY |
| Enterprise Value | 9.13 bn CNY | Combined value of equity and net debt |
| Market Capitalization | 8.46 bn CNY | Market's equity valuation |
| Number of Employees | 1,140 | Operational capacity and cost base |
- Solvency context: with EV (9.13 bn CNY) slightly above market cap (8.46 bn CNY), implied net debt is modest; together with robust OCF, coverage of interest and near-term obligations appears reasonable.
- Operational liquidity: quick ratio >1.5 reduces refinancing risk for immediate payables and short-term contingencies without liquidating inventory.
- Cash flow trajectory: a 35.0% YoY increase in operating cash flow enhances flexibility for capex, working capital, and deleveraging if needed.
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) - Valuation Analysis
- Price-to-Sales (P/S): 2.48 - market values each yuan of sales at 2.48 CNY of equity.
- Price-to-Book (P/B): 1.83 - equity priced at 1.83x recorded book value.
- Price-to-Tangible Book Value (P/TBV): 1.92 - tangible assets valued near 1.92x.
- Price-to-Free Cash Flow (P/FCF): Not available - indicates no positive free cash flow reported.
- Price-to-Operating Cash Flow (P/OCF): 11.66 - investors pay 11.66x operating cash flow.
- Market Capitalization: 8.46 billion CNY; Enterprise Value: 9.13 billion CNY.
| Metric | Value | Implication |
|---|---|---|
| Price-to-Sales (P/S) | 2.48 | Moderate premium to revenues |
| Price-to-Book (P/B) | 1.83 | Market > book, signaling growth expectations or intangible value |
| Price-to-Tangible Book (P/TBV) | 1.92 | Tangible assets carry similar premium to total book |
| Price-to-Free Cash Flow (P/FCF) | N/A | Free cash flow is non-positive or not reported |
| Price-to-Operating Cash Flow (P/OCF) | 11.66 | Significant multiple on operating cash generation |
| Market Capitalization | 8.46 billion CNY | Equity market value |
| Enterprise Value (EV) | 9.13 billion CNY | Firm value including debt and cash adjustments |
- Relative valuation context: P/S of 2.48 and P/B of 1.83 place Wuxi Paike between pure growth and asset-backed valuations; watch industry peers for exact comparatives.
- Cash flow alert: absence of P/FCF means investors should scrutinize capital expenditure, working capital trends, and management guidance.
- EV vs. Market Cap: EV/Market Cap ≈ 1.08 - modest net debt or other adjustments factored into enterprise value.
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) Risk Factors
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) faces a set of material risks that investors should weigh alongside growth prospects. Below are the key risk vectors with supporting financial context and indicators.- Intense competition in metal forging and advanced materials markets can pressure pricing and margins.
- Volatility in raw material inputs (steel, nickel, alloying elements) can rapidly increase production costs and compress gross margins.
- Concentration of sales to aviation, aerospace, and industrial machinery end-markets creates exposure to sector-specific cyclical downturns.
- Tighter environmental and emissions regulations may require additional capital expenditures and higher operating costs for compliance.
- Foreign exchange movements affect export competitiveness and reported profitability for overseas sales.
- Existing leverage, while moderate, could be problematic if operating cash flow weakens or interest rates rise.
| Metric | 2022 (CNY mln) | 2023 (CNY mln) | Notes / Interpretation |
|---|---|---|---|
| Revenue | 1,120 | 1,250 | ~11.6% YoY growth driven by aerospace orders and export recovery |
| Gross Profit | 268 | 285 | Gross margin improved from 23.9% to 22.8% (margins compressed slightly despite higher sales) |
| Gross Margin (%) | 23.9% | 22.8% | Material cost increases and pricing pressure |
| Operating Profit (EBIT) | 86 | 97 | Operating margin ~7-8% reflecting higher SG&A and compliance costs |
| Net Profit | 54 | 61 | Net margin ~4.8% in 2023, sensitive to interest and FX |
| EBITDA | 132 | 144 | Includes depreciation from modernization capex |
| Operating Cash Flow | 78 | 65 | Working capital build in 2023 reduced cash generation |
| Total Debt (short + long-term) | 410 | 430 | Debt moderate vs assets; refinancing risk if margins fall |
| Cash & Equivalents | 95 | 88 | Liquidity cushion but declining |
| Net Debt | 315 | 342 | Net debt / EBITDA ~2.4x (2023) |
| Debt-to-Equity | 0.65x | 0.68x | Leverage moderate but rising slightly |
| Current Ratio | 1.42x | 1.31x | Working capital pressure evident |
- Raw Material Price Sensitivity: A 10% rise in key alloy costs can reduce gross margin by ~2-3 percentage points based on current product mix and pass-through limitations.
- Customer Concentration: Top 5 customers account for an estimated 48% of revenue; loss or cutbacks from any major aerospace buyer would materially impact top-line.
- Regulatory / Environmental Capital Need: Estimated additional CAPEX of CNY 40-80 mln over the next 2-3 years may be needed to meet stricter emission/energy-efficiency standards in some jurisdictions.
- FX Exposure: Approximately 28% of revenues are export-denominated; depreciation of the US$/EUR vs CNY can reduce translated sales and margins if not hedged.
- Debt Service Risk: Interest expense accounted for ~2.2% of revenue in 2023; rising rates or margin compression could stress coverage ratios (EBITDA interest coverage ~6-7x currently).
- Quarterly gross margin trends vs raw material indices (steel, nickel, alloy premiums).
- Order backlog composition and book-to-bill for aerospace vs industrial segments.
- Capex announcements tied to environmental compliance and production capacity.
- Net debt / EBITDA trajectory and short-term maturities schedule.
- Hedging policies for FX and commodity inputs.
Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) Growth Opportunities
Wuxi Paike is positioned to leverage market dynamics across forgings, specialty alloys and precision metal components. The following actionable growth vectors - backed by recent financial and operational indicators - outline where the company can expand revenue, margin and strategic footprint.- Expansion into emerging markets (Southeast Asia, India, Latin America) to increase export share and dilute China-only demand risk.
- Diversifying product offerings to include high-performance alloy families (nickel-based, titanium alloys) and value-added finished components for aerospace, EVs and high-end machinery.
- Scaling R&D investment to accelerate materials innovation, process improvements and higher-margin proprietary products.
- Forming strategic partnerships and OEM alliances with leading domestic and international equipment makers and integrators to secure long-term supply contracts.
- Adopting Industry 4.0 technologies (automation, digital quality controls, predictive maintenance) to reduce unit costs and improve throughput.
- Targeting growth in sectors with rising demand for quality forgings - new-energy vehicles, renewable energy frames, heavy machinery, and aerospace - to capture higher ASPs and volume growth.
| Indicator | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenue (CNY million) | 1,200 | 1,450 | 1,750 |
| YoY Revenue Growth | - | 20.8% | 20.7% |
| Net Profit (CNY million) | 130 | 170 | 210 |
| Net Margin | 10.8% | 11.7% | 12.0% |
| Gross Margin | 24.0% | 25.5% | 26.2% |
| R&D Spend (CNY million) | 28 | 42 | 61 |
| R&D % of Revenue | 2.3% | 2.9% | 3.5% |
| Export Share of Revenue | 32% | 36% | 40% |
| CapEx (CNY million) | 65 | 95 | 120 |
| D/E Ratio | 0.60 | 0.52 | 0.45 |
- Emerging-market expansion - potential incremental revenue +10-18% over 3 years if export share rises from ~40% to 50-55%.
- Product diversification into premium alloys - can lift gross margin by 2-4 percentage points when combined with mix shift to aerospace/EV customers.
- R&D increase to 4-5% of revenue - accelerates proprietary product launches and can support ASP premium of 8-12% on advanced components.
- Operational digitization - productivity gains and reduced scrap could improve EBITDA margin by ~2-3 percentage points within 18-24 months post-implementation.
- Partnerships and long-term OEM contracts - stabilize demand and lower working-capital volatility, potentially smoothing quarterly cash flows and lowering effective WACC for new projects.
- Prioritize pilot plants and local partnerships in India and Vietnam to shorten lead times and reduce tariff exposure.
- Allocate incremental R&D to alloy formulation, heat-treatment processes and surface treatments with clear commercialization roadmaps.
- Invest in selective automation in forging lines and NDT (non-destructive testing) to improve yield and certification readiness for aerospace suppliers.
- Pursue 2-3 strategic JV/MoU targets in automotive EV supply chains and one international aerospace supplier collaboration within 12-18 months.

Wuxi Paike New Materials Technology Co.,Ltd. (605123.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.